Cormorant Asset Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-450,000
| Closed | -$61.3M | – | 116 |
|
|
2020
Q3 | $61.3M | Sell |
450,000
-150,000
| -25% | -$15.9M | 2.36% | 10 |
|
|
2020
Q2 | $58M | Sell |
600,000
-100,000
| -14% | -$8.34M | 2.21% | 14 |
|
|
2020
Q1 | $32.8M | Hold |
700,000
| – | – | 1.52% | 20 |
|
|
2019
Q4 | $51M | Buy |
700,000
+257,000
| +58% | +$15.6M | 2.04% | 16 |
|
|
2019
Q3 | $23.1M | Sell |
443,000
-57,000
| -11% | -$3.03M | 1.41% | 25 |
|
|
2019
Q2 | $25.1M | Sell |
500,000
-100,000
| -17% | -$4.87M | 1.44% | 23 |
|
|
2019
Q1 | $31.2M | Sell |
600,000
-77,451
| -11% | -$3.57M | 2.11% | 18 |
|
|
2018
Q4 | $33.1M | Sell |
677,451
-22,549
| -3% | -$1.24M | 2.69% | 12 |
|
|
2018
Q3 | $45.6M | Sell |
700,000
-67,363
| -9% | -$3.96M | 2.97% | 11 |
|
|
2018
Q2 | $38M | Hold |
767,363
| – | – | 2.81% | 10 |
|
|
2018
Q1 | $37.4M | Sell |
767,363
-32,637
| -4% | -$1.7M | 2.79% | 9 |
|
|
2017
Q4 | $33.7M | Sell |
800,000
-271,889
| -25% | -$10.5M | 3.53% | 7 |
|
|
2017
Q3 | $45.9M | Buy |
1,071,889
+71,889
| +7% | +$2.29M | 8.11% | 1 |
|
|
2017
Q2 | $13.1M | Sell |
1,000,000
-130,000
| -12% | -$1.71M | 2.17% | 17 |
|
|
2017
Q1 | $14.9M | Sell |
1,130,000
-315,090
| -22% | -$4.04M | 2.16% | 16 |
|
|
2016
Q4 | $18.7M | Sell |
1,445,090
-160,700
| -10% | -$2.48M | 2.52% | 14 |
|
|
2016
Q3 | $26.2M | Buy |
1,605,790
+847,500
| +112% | +$15.3M | 2.89% | 10 |
|
|
2016
Q2 | $9.4M | Buy |
758,290
+4,902
| +0.7% | +$61.3K | 1.33% | 26 |
|
|
2016
Q1 | $8.07M | Hold |
753,388
| – | – | 1.22% | 31 |
|
|
2015
Q4 | $11M | Buy |
+753,388
| New | +$9.21M | 1.32% | 31 |
|
Cormorant Asset Management's MYOK Position: Q4 2020 in Review
Cormorant Asset Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 450,000 shares — an estimated $61.3M sold.
Cormorant Asset Management first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $61.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Cormorant Asset Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Cormorant Asset Management sold 450,000 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $61.3M.
- Cormorant Asset Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Cormorant Asset Management's MyoKardia, Inc. Common Stock position peaked at $61.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Cormorant Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.